ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
Oncotarget (2014) - Comments
pubmed: 24952873  doi: 10.18632/oncotarget.1955  issn: 1949-2553 

Katharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, Merel Gijsen, Tzi Bun Ng, Jack Ho Wong, Carla Strina, Mariarosa Cappelletti, Daniele Andreis, Ji-Liang Li, Esther Bridges, Helen Turley, Russell Leek, Ioannis Roxanis, Jacek Capala, Gillian Murphy, Adrian L. Harris, Anthony Kong